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2302to lead to serious adverse clinical events. Second,
they highlight a novel concern from the imaging
standpoint—that gated studies may be rendered
nondiagnostic due to pacemaker interference.
Finally, these cases further emphasize a point
touched on by the authors in their discussion. That
is, while routine CT studies are unlikely to cause
serious clinical events, this cannot be extrapolated
to other applications that may involve longer
exposure of a rhythm management device to CT
irradiation.
Fortunately, these cases are uncommon for seve-
ral reasons. First, transient suppression of pace-
maker function only occurred when the beam was in
line with the generator. Thus, when the generator is
positioned higher in the chest, it is less likely to
suffer from interference while scanning cardiac
structures. Second, because the effect was ventric-
ular oversensing, only patients who are pacemaker
dependent are affected. Finally, the cases that will
be affected are those for which multiple phases of
the cardiac cycle are necessary for dynamic evalua-
tion (e.g. ventricular function), and coronary imag-
ing may still be possible using a single cardiac phase.
While ventricular function is not a common indica-
tion for cardiac CT, it is often indicated for patients
who have poor acoustic windows on echocardiogra-
phy and cannot undergo magnetic resonance imag-
ing (i.e., with indwelling pacemaker). Knowledge of
this fact is useful, as patients who are pacemaker
dependent and are undergoing cardiac CT for eval-
uation of ventricular function can have their pace-
maker settings changed to an asynchronous pacing
mode prior to the examination to avoid potential
oversensing.*Robert Donnino, MD
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Imaging on Rhythm Devices in
Real-World PracticeWe would like to thank Dr. Donnino and colleagues
for their valuable comments regarding our study on
the safety of computed tomography (CT) imaging in
patients with cardiac rhythm management (CRM)
devices (1). We agree with the authors’ comments
regarding electrocardiography (ECG)-gated studies in
patients who are pacemaker dependent. In clinical
practice, non–ECG-gated CT is by far a more common
situation in which CRM devices would be exposed to
radiation and it was in this context that the original
Food and Drug Administration advisory was
prompted. ECG-gated studies are typically associated
with higher radiation doses than conventional CT
scanning and theoretically would be more likely to
interfere with CRM devices. Classically, the doses
of ECG-gated CT studies have ranged from 12
to 23 mSv depending on protocol and vendor.
However, the most current techniques of prospective
triggering and iterative reconstruction have helped
to reduce radiation doses to ranges comparable to
and even below the doses seen with conventional
studies.
As pointed out by Dr. Donnino and colleagues, CT
scans are rarely performed for the evaluation of left
ventricular (LV) function. In pacemaker-dependent
patients who are undergoing cardiac ECG-gated CT
imaging, the assessment of LV function would be
compromised by CT interference due to oversensing
and pacing inhibition. While the scenario proposed by
the authors is not commonly encountered, it is
important to recognize to choose the most appro-
priate imaging study and to avoid unnecessary radi-
ation exposure to patients. Pre-CT programming of
the device to an asynchronous pacing mode would be
warranted to avoid the effect of such interference on
CT quality and to be able to assess LV function.
Oversensing with pacing inhibition would be
limited to the duration of direct exposure of the device
to radiation beams (2,3) and for the vast majority of
diagnostic CT exams would not affect CT quality. Most
importantly, routine diagnostic CT imaging appears to
be safe and less likely to result in clinically signiﬁcant
events, as suggested by our ﬁndings. For patients in
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2303whom CT imaging may expose the device to direct
radiation beams for longer than a few seconds, such as
in patients undergoing CT-guided interventions,
oversensing with pacing inhibition would carry signi-
ﬁcant risks, including a systole, whichmight be under-
estimated by clinicians performing such interventions.
Our ﬁndings from routine diagnostic CT scans cannot
be extrapolated to this group of patients. Shall such
procedures be clinically required in pacemaker-
dependent patients; programming of the device to an
asynchronous pacing mode would be needed to avoid
the clinical consequences of oversensing.Ayman Hussein, MD
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